Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 14Terminated 4Unknown 3Recruiting 2

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, T-Cell, Peripheral 1Lymphoma, Follicular 1Lymphoma, B-Cell 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Transplantation, Autologous × Clear all
NCT04489264 2020-12-04

The Role of Consolidative Autologous Stem Cell Transplantation After First-line Therapy in Peripheral T Cell Lymphoma

Peking University

Unknown
60 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03681938 2018-09-24

Indication to Transplant Patients With High Risk B Cells Lymphoma in Metabolic Complete Remission?

Institut Paoli-Calmettes

Unknown
183 enrolled
Lymphoid

Lymphoma, B-Cell

NCT00435955 2007-02-16

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Azienda Ospedaliera San Giovanni Battista

Phase 3 Unknown
240 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡